| Jul 24 2025 |
FDA Issues Warning Letters for Products Containing 7-Hydroxymitragynine |
Keller and Heckman LLP |
| Jul 23 2025 |
EPA Seeks Comment on New Plan to Track the Adoption of Bilingual End-Use Pesticide Labels |
Bergeson & Campbell, P.C. |
| Jul 23 2025 |
Legislation Introduced to Amend FIFRA to Establish a Private Right of Action for Injuries Caused by Pesticides |
Bergeson & Campbell, P.C. |
| Jul 23 2025 |
This Week in 340B: July 15 – 21, 2025 |
McDermott Will & Schulte LLP |
| Jul 23 2025 |
Trending in Telehealth: June 2025 |
McDermott Will & Schulte LLP |
| Jul 23 2025 |
Federal Court Issues Preliminary Injunction Against Iowa PBM Law, Citing ERISA Preemption and First Amendment Violations |
Mintz |
| Jul 23 2025 |
CMS CY 2026 Proposed Rules: 340B in PFS and OPPS |
McDermott Will & Schulte LLP |
| Jul 23 2025 |
The BR International Trade Report: July 2025 |
Blank Rome LLP |
| Jul 23 2025 |
Ninth Circuit Applies EKRA to Marketing Intermediaries in Lab Operator’s Allergy Testing Scheme |
Epstein Becker & Green, P.C. |
| Jul 23 2025 |
OIG Advisory Opinion 25-07 Offers a Favorable Path for Patient Access Through Sponsored Testing |
Epstein Becker & Green, P.C. |
| Jul 22 2025 |
June 2025 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Jul 22 2025 |
GLP-1 Receptor Agonists: Clinical Trial Considerations |
Foley & Lardner LLP |
| Jul 22 2025 |
Reefer Madness: Congressional Proposal Would Keep Marijuana Schedule I, Prevent Most Prosecutions of Marijuana Use |
Bradley Arant Boult Cummings LLP |
| Jul 21 2025 |
FDA Seeks Public Comment on Post-Market Chemical Review Prioritization Method |
Beveridge & Diamond PC |
| Jul 21 2025 |
MAHA Assessment: What Food and Chemical Stakeholders Need to Know |
Beveridge & Diamond PC |
| Jul 21 2025 |
Why 340B Data Must Be Part of CMS's Medicaid Pharmacy Surveys |
Jones Walker LLP |
| Jul 21 2025 |
Lexicography: Clear And Unequivocal |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 21 2025 |
FDA Warning Letter Reminds Industry that Wellness Claims Only Go So Far, Other Features Can Establish Intended Use |
Mintz |
| Jul 20 2025 |
FDA to Overhaul Post-Market Chemical Review Program for Food Chemicals |
Beveridge & Diamond PC |
| Jul 19 2025 |
FDA Announces Plans to Revoke 52 Standards of Identity for Food Products |
Keller and Heckman LLP |
| Jul 19 2025 |
FDA Extends Comment Period for Proposed Method for Ranking Chemicals in the Food Supply |
Keller and Heckman LLP |
| Jul 19 2025 |
FDA Calls on Infant and Children’s Food Brands to Improve Recall Communications |
Keller and Heckman LLP |
| Jul 19 2025 |
FDA Commissioner Marks His First 100 Days |
Keller and Heckman LLP |
| Jul 19 2025 |
Cultured Salmon Company Receives “No Questions” Letter From FDA |
Keller and Heckman LLP |
| Jul 18 2025 |
FDA Authorizes JUUL Labs ENDS Products for U.S. Market |
Keller and Heckman LLP |
| Jul 18 2025 |
FDA Extends Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments |
Bergeson & Campbell, P.C. |
| Jul 18 2025 |
APHIS Updates Practices for Reviewing Petitions Seeking a Determination of Nonregulated Status for Organisms Altered or Produced through Genetic Engineering |
Bergeson & Campbell, P.C. |
| Jul 18 2025 |
McDermott+ Check-Up – July 18, 2025 |
McDermott Will & Schulte LLP |
| Jul 17 2025 |
Defra Begins Public Consultation on Extending UK REACH Transitional Registration Submission Deadlines |
Bergeson & Campbell, P.C. |
| Jul 17 2025 |
Ninth Circuit Court of Appeals Affirms EKRA Conviction for Lab Operator and Provides Insight into Key Provisions |
Mintz |
| Jul 17 2025 |
Motivation, Expectation of Success Negate Obviousness Presumption in Overlapping Range Case |
McDermott Will & Schulte LLP |
| Jul 17 2025 |
An Increasing Regulatory Maze for Nontraditional Meat Products |
Womble Bond Dickinson (US) LLP |
| Jul 17 2025 |
DOJ Targets Gender‑Affirming Care under FDCA and FCA: Scrutinizes Off‑Label Drug Use and False Diagnosis Codes |
Proskauer Rose LLP |
| Jul 16 2025 |
This Week in 340B: July 8 – 14, 2025 |
McDermott Will & Schulte LLP |
| Jul 16 2025 |
Shielding Reproductive Freedom: Uncovering New York’s Law Protecting Providers from Civil and Criminal Liability |
Epstein Becker & Green, P.C. |
